Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For TRMD-A.CO
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
17%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 39.34 3.63 2.60
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -27.13 2.92 4.01
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 20.99 22.98 18.99
Cash 119.41 6.65 3.03
Capex -54.63 -2.69 -1.74
Free Cash Flow 26.61 -0.61 0.48
Revenue 11.72 4.95 4.43
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 10.53 0.65 0.59
Operating Margin -0.43 0.50 0.50
ROA -7.26 0.06 0.06
ROE -8.60 0.10 0.11
ROIC -8.41 0.07 0.07
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of TRMD-A.CO is permitted for members.
5 Growth
The "Growth Entry" for the Focus of TRMD-A.CO is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of TRMD-A.CO is permitted for members.